| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/13/2013 | EP2567979A1 Use of neutralizing prolactin receptor antibodies for the treatment of hyper- and normoprolactinemic hair loss |
| 03/13/2013 | EP2567978A1 Use of neutralizing prolactin receptor antibodies for contraception |
| 03/13/2013 | EP2567977A1 Use of neutralizing prolactin receptor antibodies for the treatment of benign breast disease and mastalgia |
| 03/13/2013 | EP2567976A2 Antibodies against CD38 for treatment of multiple myeloma |
| 03/13/2013 | EP2567974A2 Monoclonal antibodies to progastrin |
| 03/13/2013 | EP2567973A2 IL-21 antagonists |
| 03/13/2013 | EP2567971A2 Peptide vaccines comprising Seq Id 80, 100 or 101 for cancers expressing tumor-associated antigens |
| 03/13/2013 | EP2567967A2 Method of using adenoviral vectors to induce an immune response |
| 03/13/2013 | EP2567709A2 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6) |
| 03/13/2013 | EP2567708A2 Preservation by vaporization |
| 03/13/2013 | EP2567707A2 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 03/13/2013 | EP2567706A2 Peptide sequences and compositions |
| 03/13/2013 | EP2567234A1 Diagnostic method for the detection of cells ex vivo |
| 03/13/2013 | EP2566967A1 Detection and treatment of fibrosis |
| 03/13/2013 | EP2566958A1 Novel method |
| 03/13/2013 | EP2566956A1 Lentiviral vector based immunological compounds against malaria |
| 03/13/2013 | EP2566895A2 Anti-erbb3 antibodies |
| 03/13/2013 | EP2566894A1 Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies |
| 03/13/2013 | EP2566893A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/13/2013 | EP2566892A1 Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies |
| 03/13/2013 | EP2566890A2 Anti-pai-1 antibodies and methods of use thereof |
| 03/13/2013 | EP2566889A1 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column |
| 03/13/2013 | EP2566884A2 Genetic signatures in hiv-1 subtype c envelope glycoproteins |
| 03/13/2013 | EP2566521A2 Immunogen adherence and method of making and using same |
| 03/13/2013 | EP2566520A1 Methods for the treatment of il-1 related conditions |
| 03/13/2013 | EP2566519A2 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
| 03/13/2013 | EP2566518A1 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells |
| 03/13/2013 | EP2566517A2 Antibodies that bind csf1r |
| 03/13/2013 | EP2566516A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases |
| 03/13/2013 | EP2566515A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases |
| 03/13/2013 | EP2566514A2 Methods of inhibiting fibrosis using anti-pai-1 antibodies |
| 03/13/2013 | EP2566513A1 Gfi1b modulation and uses thereof |
| 03/13/2013 | EP2566512A1 Antibodies against epidermal growth factor receptor (egfr) and uses thereof |
| 03/13/2013 | EP2566511A2 Use of an anti-cd71 antibody for preparing a medicament |
| 03/13/2013 | EP2566510A1 Compositions and methods useful for reducing the viscosity of protein-containing formulations |
| 03/13/2013 | EP2566509A1 Novel antibody to a carbonic anhydrase |
| 03/13/2013 | EP2566508A2 Polysaccharide conjugation with detoxified e. coli heat labile enterotoxin (lt) used as vaccine |
| 03/13/2013 | EP2566507A1 Capsular gram-positive bacteria bioconjugate vaccines |
| 03/13/2013 | EP2566506A1 Vaccine composition for preventing or treating leishmaniases |
| 03/13/2013 | EP2566499A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
| 03/13/2013 | EP2566496A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases |
| 03/13/2013 | EP2566490A2 Biologic female contraceptives |
| 03/13/2013 | EP2566484A2 Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses |
| 03/13/2013 | EP1392359B2 Specific binding proteins and uses thereof |
| 03/13/2013 | CN1984672B Modulation of NKG2D |
| 03/13/2013 | CN1761756B Depletion of endogenous primordial germ cells in avian species |
| 03/13/2013 | CN1578785B Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 03/13/2013 | CN1519311B Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents |
| 03/13/2013 | CN102971425A Live attenuated chimeric porcine circovirus vaccine |
| 03/13/2013 | CN102971417A Isolation of a virus related to canine parvovirus-2 from a raccoon |
| 03/13/2013 | CN102971340A Antibodies with enhanced or suppressed effector function |
| 03/13/2013 | CN102971012A CD37-binding molecules and immunoconjugates thereof |
| 03/13/2013 | CN102971011A Vaccine compositions based on sticholysin encapsulated in liposomes |
| 03/13/2013 | CN102971010A Recombinant CDV compositions and uses thereof |
| 03/13/2013 | CN102971009A Purification of staphylococcus aureus type 5 and type 8 capsular saccharides |
| 03/13/2013 | CN102971008A Vaccine and methods to reduce campylobacter infection |
| 03/13/2013 | CN102971007A Biologic female contraceptives |
| 03/13/2013 | CN102971003A Improved cancer therapy based on tumor associated antigens derived from cyclin D1 |
| 03/13/2013 | CN102965348A Bovine viral diarrhea-mucosal virus with modified erns protein |
| 03/13/2013 | CN102965345A Porcine parvovirus, vaccine composition and application thereof |
| 03/13/2013 | CN102965344A Production of infectious bronchitis virus and vaccine from cell line |
| 03/13/2013 | CN102965332A Swine testicular clone cell line and production method of classical swine fever live vaccine |
| 03/13/2013 | CN102964434A Recombinant encephalitis B virus and application thereof |
| 03/13/2013 | CN102964433A High immunogenicity rabies virus glycoprotein, its preparation method and application |
| 03/13/2013 | CN102964432A Method for restraining phosphorylation of M1 protein of influenza virus A and applications of method |
| 03/13/2013 | CN102964426A Tumor antigens for prevention and/or treatment of cancer |
| 03/13/2013 | CN102961757A Pseudovirus particle vaccine carrying double-stranded RNA target antigen and neutralizing antigen |
| 03/13/2013 | CN102961747A Treatment of metastatic breast cancer |
| 03/13/2013 | CN102961746A Use of tnf inhibitor for treatment of erosive polyarthritis |
| 03/13/2013 | CN102961745A Antibody composition preparation and application thereof |
| 03/13/2013 | CN102961744A Composition used for moisturizing |
| 03/13/2013 | CN102961743A Recombinant Newcastle disease LaSota attenuated vaccine strain expressing mycoplasma gallisepticum TM1protein |
| 03/13/2013 | CN102961742A Bivalent inactivated vaccine of porcine circovirus type 2 and porcine parvovirus and preparation method thereof |
| 03/13/2013 | CN102961741A Method for preparing tetanus toxoid vaccine |
| 03/13/2013 | CN102961740A Preparation method of diphtheria toxoid vaccine |
| 03/13/2013 | CN102961337A Preparation method of target compound nano particle |
| 03/13/2013 | CN102423304B Preparation method of N-2-hydroxypropyl trimethyl ammonium chloride chitosan/N, O-carboxymethyl chitosan newcastle disease attenuated live vaccine nanoparticle |
| 03/13/2013 | CN102399751B Anti-mycobacterium tuberculosis monoclonal antibody, epitope recognized by anti-mycobacterium tuberculosis monoclonal antibody, and use thereof |
| 03/13/2013 | CN102352346B Novel-pathotype duck reovirus and attenuated vaccine thereof |
| 03/13/2013 | CN102329782B Avian flavivirus isolation strain and application thereof in preparation of vaccine |
| 03/13/2013 | CN102294024B Polypeptide vaccine and preparation method thereof |
| 03/13/2013 | CN102276697B Helicobacter pylori antigen HLA restricted immuno-dominant epitope peptide and application thereof |
| 03/13/2013 | CN102234657B Fusion protein for resisting chicken coccidiosis, preparation and application thereof |
| 03/13/2013 | CN102228481B Propolis injection for preventing type I duck virus hepatitis and preparation method thereof |
| 03/13/2013 | CN102205122B Method for preparing piglet diarrhea-resisting egg yolk antibody microcapsules by spray drying method |
| 03/13/2013 | CN102085371B Medical gargle product for Xerostomia and preparation method thereof |
| 03/13/2013 | CN102000329B Improved flagellin mucosa adjuvant from non-pathopoiesia bacteria source and preparation method thereof |
| 03/13/2013 | CN101980721B Antigendrug excipient comprising synthetic peptide, and mucosal vaccine using the same |
| 03/13/2013 | CN101914458B Candida albicans (mannose protein complex) strain |
| 03/13/2013 | CN101888853B Use of MVA to treat prostate cancer |
| 03/13/2013 | CN101659696B Asia I-type aftosa synthetic peptide vaccine |
| 03/13/2013 | CN101405030B Use of an antibody for vascular endothelial groeth factor and an antibody for human epithelial growth factor receptor type 2 in preparing kit for tumor therapy |
| 03/13/2013 | CN101309931B Vaccines comprising truncated HBC core protein plus saponin-based adjuvants |
| 03/13/2013 | CN101304760B Dengue virus capsid protein which induces a protective response and pharmaceutical composition |
| 03/13/2013 | CN101134779B Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 03/13/2013 | CN101119744B Polypeptides from S. aureus and methods of use |
| 03/13/2013 | CN101058800B Animal protein free media for cultivation of cells |
| 03/13/2013 | CN101048659B Monoclonal antibodies to progastrin |
| 03/13/2013 | CN101048175B Immunogenic bacterial vesicles with outer membrane proteins |
| 03/13/2013 | CN101001873B Variant fc regions |